Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.08 +0.07 (+3.54%)
As of: Oct 21, 2026 · 1:56 PM EDT

Foghorn Therapeutics (FHTX) Preferred Stock Liabilities (2019 - 2020)

Updated

Foghorn Therapeutics (FHTX) posted Preferred Stock Liabilities of $176.41 million for Q3 2020.

Analysis

Foghorn Therapeutics (FHTX) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Foghorn Therapeutics' Preferred Stock Liabilities came in at $86.54 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn -
2 Johnson & Johnson 616.11 Bn 534.64 Bn 17.26 Bn -
3 AbbVie 501.21 Bn 474.32 Bn 12.70 Bn -
4 Merck 367.51 Bn 321.89 Bn 12.21 Bn -
5 Novartis Ag 297.95 Bn 261.94 Bn 11.24 Bn -
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn -
7 Amgen 235.88 Bn 191.28 Bn 7.24 Bn -
8 Gilead Sciences 190.74 Bn 164.94 Bn 6.22 Bn -
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn -
10 Foghorn Therapeutics 146.91 Mn -179.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 176.41 Mn
Dec 31, 2019 86.54 Mn
API Access

Foghorn Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=FHTX&period=max&api_key=YOUR_API_KEY